Fintel reports that on January 12, 2026, Argus Research downgraded their outlook for Hologic (NasdaqGS:HOLX) from Buy to Hold ...

What Hologic’s recent performance could mean for investors Hologic (HOLX) has been drawing fresh attention after a mix of ...

Hologic is scheduled to release its first-quarter results soon, with analysts projecting single-digit growth in its bottom ...

Shares of Hologic HOLX closed the first trading session of the year at $74.56, which is quite close to the 52-week high of $75.34, reached on Dec. 15, 2025. In the past six months, the company has ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI ® Detection 2.0 software across diverse patient ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

Women’s health tech company Hologic is launching "Better is Possible," a new health education and awareness campaign aimed at getting women to talk to their doctors about their disruptive period ...

Powerful artificial intelligence combined with digital imaging designed to transform screening Genius™ Digital Diagnostics System for Cervical Cancer Screening (Photo: Business Wire) For more than 30 ...

On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today launched Project Health Equality (PHE), a unique initiative that strives to address the ...

Though the vast majority of women are aware of the importance of early screening for various cancers and other life-threatening health conditions, a new survey estimates that nearly half of those in ...